NCT02094469View on ClinicalTrials.gov

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Vasospastic Angina
Interventions
DRUG

Cilostazol

Oral, Bid, 24 weeks

Trial Locations (1)

626-770

Yangsan Busan University Hospital, Busan

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY